Advertisement IDEX agrees to acquire Microfluidics International - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

IDEX agrees to acquire Microfluidics International

IDEX has entered into a definitive merger agreement to acquire Microfluidics International, a manufacturer of laboratory and commercial equipment used in the production of micro and nano scale materials for the pharmaceutical and chemical markets.

Microfluidics’ product and service offerings are expected to enhance IDEX’s micro fluidics and micro particle technology position.

Microfluidics will operate as a stand-alone business within the IDEX Fluid and Metering segment.

IDEX chairman and CEO Larry Kingsley said Microfluidics’ leading technology in particle size reduction and nano-particle creation adds enabling technology to one of their key platforms supporting pharmaceutical research and production.

"Combining Microfluidics with our Quadro and Fitzpatrick pharma platform will allow for significant growth opportunities across the globe. We welcome the Microfluidics team to IDEX," Kingsley said.

Microfluidics CEO Michael Ferrara said the company has completed a significant transformation – evolving into an innovative, efficient and financially stable technology provider with a robust product line that continues to serve as the gold standard for nano-materials processing, particularly for pharmaceutical applications.